Clinical Trials Logo
  1. Home
  2. IPMN
  3. NCT03305146

Feasibility of Molecular Biology in Pancreatic Cyst Tumors — CYST-GEN  

Pancreatic Cyst Clinical Trial

Official title:
Study of Feasibility and Diagnostic Profitability of Intra-cyst Fluid Molecular Biology Analysis in Pancreatic Cyst Tumors.

Clinical Trial Summary

The main objective of the study is to compare the diagnostic accuracy of intra-cystic fluid DNA molecular analysis to standard diagnostics. The secondary objective of the study is to evaluate the feasibility of intra-cystic fluid DNA molecular analysis.

Clinical Trial Description

Multicenter study to determinate the feasibility of intra-cystic fluid DNA molecular analysis in patients with suspected cystic tumours of pancreas in whom EUS FNA is clinically indicated. Morphological criteria obtained by MRI and computerised tomography (tumor characterization (size, metastases presence, dilatation of bile ducts), etiologic diagnosis, serious symptoms), biological exams (biomarkers), cytological analysis will lead to a diagnosis and a treatment. The goal of this study is to compare this standard diagnostic modalities to diagnosis obtained by intra-cystic fluid DNA molecular analysis. Is the DNA molecular analysis improve the diagnosis accuracy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03305146
Study type Interventional
Source Hospital St. Joseph, Marseille, France
Contact
Status Active, not recruiting
Phase N/A
Start date January 2017
Completion date January 2027
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05572788 - Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts N/A
Completed NCT01770405 - Clinical Registry of nCLE in Masses and Cystic Tumors of the Pancreas, Lymph Nodes, Submucosal Lesions of the GI Tract N/A
Completed NCT01643460 - Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts N/A
Recruiting NCT03260842 - Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
Recruiting NCT04291651 - UCSF PANC Cyst Registry
Recruiting NCT05692596 - The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics
Recruiting NCT03334708 - A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
Recruiting NCT04140435 - EUS-guided Through-the-needle Microforceps Biopsy Outcomes
Terminated NCT00550108 - Management of Incidentally Discovered Pancreatic Cysts Phase 3
Recruiting NCT03492151 - Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions
Completed NCT03169842 - Cyst Fluid Glucose for On-site Diagnosis of Mucinous Pancreatic Cysts N/A
Not yet recruiting NCT06320990 - Chemoprevention With Tamoxifen in Pre-Invasive Pancreas Mucinous Cystic Neoplasms Not Undergoing Immediate Resection Phase 1
Recruiting NCT04404101 - Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies N/A
Recruiting NCT06305728 - A Study of Early Cancer Detection in People at High Risk of Developing Pancreatic Ductal Adenocarcinoma (PDAC)
Recruiting NCT06340620 - EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope N/A
Recruiting NCT02343692 - A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas N/A
Recruiting NCT02775461 - Pancreas Registry and High Risk Registry
Active, not recruiting NCT01563133 - Clinical Evaluation Of Needle-based Confocal Laser Endomicroscopy in The Lymph Nodes Along With Masses and Cystic Tumors of the Pancreas N/A
Completed NCT00222898 - Cancer Detection in Pancreatic Cysts N/A
Completed NCT03740360 - Contrast Enhanced Ultrasound and Molecular Analysis in the Diagnosis of Pancreatic Cyst